Biophytis
Naim MJAMER has worked in the pharmaceutical industry since 2009. Naim started as a CMC Regulatory Project Manager and CMC Regulatory Officer at Sanofi from 2009 to 2013. Naim then worked as a CMC Regulatory Project Manager at MINAKEM from 2013 to 2016. From 2016 to 2018, they were a Pharmaceutical Development Project Manager at Recordati Rare Diseases. Naim then moved to GENFIT where they worked as a CMC & Pharmaceutical Development Project Manager from 2018 to 2021. Currently, they are a CMC & Pharmaceutical Development Manager at Biophytis - LIVE HEALTHIER LONGER.
Naim MJAMER completed a Master in Chimie from the Faculté des Sciences de Reims in 2007-2008. Naim then went on to receive a Master 2 in Médicament: Qualité et Réglementation from the Faculté de Pharmacie de Reims in 2008-2009.
This person is not in any offices
Biophytis
Biophytis develops drug candidates targeting diseases of aging. Using its technology and know-how, Biophytis has begun clinical development of innovative therapeutics to restore the muscular and visual functions in diseases with significant unmet medical needs.